Literature DB >> 518143

An evaluation of criteria for polymyalgia rheumatica.

H A Bird, W Esselinckx, A S Dixon, A G Mowat, P H Wood.   

Abstract

There has been little basis on which to standardise a diagnosis of polymyalgia rheumatica (PMR), and so 11 rheumatology units in the south and west of Great Britain have collaborated in a study to evaluate possible criteria. Symptoms and laboratory findings claimed to be of diagnostic value in PMR were included in an analysis of the features of 236 patients considered to have unequivocal PMR and 70 patients thought to have possible PMR. The results were compared with similar information from 253 patients with conditions that mimic PMR and from 201 consecutive new presentations to outpatients. The 7 most valuable criteria for differentiation were bilateral shoulder pain or stiffness, onset of illness of less than 2 weeks' duration, initial ESR greater than 40 mm/h, duration of morning stiffness exceeding 1 hour, age 65 years or more, depression and/or weight loss, and bilateral tenderness in the upper arms. We suggest that a patient might be regarded as having probable PMR if any 3 or more of these criteria are fulfilled, or if at least 1 criterion coexists with a clinical or pathological abnormality of the temporal artery. A standardised therapeutic test with prednisolone has value in making the diagnosis of PMR more certain.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 518143      PMCID: PMC1000388          DOI: 10.1136/ard.38.5.434

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  5 in total

1.  Prognosis in the anarthritic rheumatoid syndrome.

Authors:  L BAGRATUNI
Journal:  Br Med J       Date:  1963-02-23

2.  A rheumatoid syndrome occurring in the elderly.

Authors:  L BAGRATUNI
Journal:  Ann Rheum Dis       Date:  1953-06       Impact factor: 19.103

3.  Polymyalgia rheumatica -- a clinical study with particular reference to arterial disease.

Authors:  A G Mowat; B L Hazleman
Journal:  J Rheumatol       Date:  1974-06       Impact factor: 4.666

4.  Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings.

Authors:  P Fauchald; O Rygvold; B Oystese
Journal:  Ann Intern Med       Date:  1972-12       Impact factor: 25.391

5.  Polymyalgia rheumatica and temporal arteritis.

Authors:  A S Dixon; C Beardwell; A Kay; J Wanka; Y T Wong
Journal:  Ann Rheum Dis       Date:  1966-05       Impact factor: 19.103

  5 in total
  98 in total

1.  Impaired redox status and cytochrome c oxidase deficiency in patients with polymyalgia rheumatica.

Authors:  P Chariot; X Chevalier; M Yerroum; I Drogou; F J Authier; R Gherardi
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

2.  Polymyalgia rheumatica: pitfalls in diagnosis.

Authors:  S Siebert; T M Lawson; M H Wheeler; J C Martin; B D Williams
Journal:  J R Soc Med       Date:  2001-05       Impact factor: 5.344

3.  Autoantibodies to recombinant lipocortin-1 in rheumatoid arthritis and systemic lupus erythematosus.

Authors:  N J Goulding; M R Podgorski; N D Hall; R J Flower; J L Browning; R B Pepinsky; P J Maddison
Journal:  Ann Rheum Dis       Date:  1989-10       Impact factor: 19.103

4.  Comment on: is Still's disease still one disease? A case of adult-onset Still's disease showing accumulation in the carotids and the large vessels of the legs on positron emission tomography: CT images.

Authors:  Veli Yazisiz; Hatice Yazisiz
Journal:  Rheumatol Int       Date:  2011-12-30       Impact factor: 2.631

Review 5.  [Polymyalgia rheumatica: myalgic syndrome or occult vasculitis?].

Authors:  B Hellmich; W L Gross
Journal:  Internist (Berl)       Date:  2005-11       Impact factor: 0.743

6.  A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica.

Authors:  H A Bird; B F Leeb; C M Montecucco; N Misiuniene; G Nesher; S Pai; C Pease; J Rovensky; B Rozman
Journal:  Ann Rheum Dis       Date:  2005-04       Impact factor: 19.103

7.  Plasminogen activator inhibitor and von Willebrand factor in polymyalgia rheumatica.

Authors:  A Uddhammar; S Rantapåå-Dahlqvist; T K Nilsson
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

8.  Reliability and validity of the Italian version of the Chronic Pain Grade questionnaire in patients with musculoskeletal disorders.

Authors:  Fausto Salaffi; Andrea Stancati; Walter Grassi
Journal:  Clin Rheumatol       Date:  2006-01-19       Impact factor: 2.980

9.  The process from symptom onset to rheumatology clinic in polymyalgia rheumatica.

Authors:  Ediz Dalkılıç; Ayşe Nur Tufan; Emre Hafızoğlu; Merve Hafızoğlu; Fatih Tufan; Ferhat Oksuz; Yavuz Pehlivan; Mustafa Yurtkuran
Journal:  Rheumatol Int       Date:  2014-05-11       Impact factor: 2.631

10.  Altered T-cell subtypes in spondyloarthritis, rheumatoid arthritis and polymyalgia rheumatica.

Authors:  Christian Dejaco; Christina Duftner; Andrea Klauser; Michael Schirmer
Journal:  Rheumatol Int       Date:  2009-05-15       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.